Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

by Marie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, Dimitrios Maltezas, Eftychia Nikolaou, Maria K. Angelopoulou, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, Mariana P. Siakandaris, Nora A. Viniou, Sotirios Sachanas, Christina Kalpadakis, Petros P. Sfikakis, Gerassimos A. Pangalis, Panayiotis Panayiotidis
Published 2014-01-01